Numerous advancements in breast cancer therapies and interventions have helped to improve outcomes and quality-of-life for countless women. Over the past seven years, growing understanding of breast cancer genetics has helped to continue this trend. The introduction of genomic testing tools, such as the Breast Cancer Index, now allow us to predict long-term prognoses for breast cancer patients better than ever before.
The Breast Cancer Index (BCI) is a test that analyzes a breast cancer patient’s genes. In women with estrogen receptor-positive (ER-positive) breast cancer, BCI predicts risk of recurrence beyond five years and predicts how […]